Monsanto

BERLIN (Reuters) - The supervisory board of Bayer is planning an extraordinary meeting to discuss a crisis of confidence in its leadership after an investor rebuke at the German drugmaker’s annual meeting, a magazine reported on Wednesday. Citing an unnamed…

Cancer lawsuits may cost Bayer billions

Bayer CEO Has 9 Months to Overcome Shareholders' Extraordinary Rebuke of His Monsanto Deal

FRANKFURT (Reuters) - Bayer shareholders on Friday cast a vote of disapproval of the German drugmaker’s top management amid anger over a stock price slump as litigation risks mount from the $63 billion takeover of seed maker Monsanto. A Bayer spokesman said…

Leaders of 300 groups across Brazil are protesting changes imposed by far-right President Jair Bolsonaro. They fear a loss of rights, and land to the interests of miners and large-scale agri-business.

Bayer's Management Face A No-Confidence Vote Over Monsanto Deal. Here's What You Need to Know.

Bayer Gets Temporary Relief from Its Monsanto-Roundup Woes

FRANKFURT (Reuters) - German drug and farming supplies company Bayer posted a 45 percent gain in quarterly core earnings thanks to the acquisition of seed maker Monsanto, while the legal burden it took on with the deal increased. Adjusted earnings before in…

Share to facebook Share to twitter Share to linkedin Agriculture workers. Photocredit: Getty Getty If science is our holy grail to truth, what happens when science finds conflicting truths? And who gets to decide which truth is true? These are…

A growing number of shareholders have said they won’t support executives and supervisory board members in the upcoming no-confidence vote. The vote has no legal weight but a low enough approval rating could be risky for the future of CEO Werner Baumann and ot…